Early closure of European Pimagedine trial [9]

Lancet

Volumn 350, Issue 9072, 1997, Pages 214-215

  Viberti, G ^a   Slama, G ^a   Pozza, G ^a   Czyzyk, A ^a   Bilous, R W ^a   Gries, A ^a   Keen, H ^a   Fuller, J H ^a   Menzinger, G ^a   Di Mario, U ^a   Navalesi, R ^a   Brunetti, P ^a   Piras, G ^a   Muggeo, M ^a   Tiengo, A ^a   Federle, D ^a   Deferrari, D ^a   Noacco, C ^a   Charbonnel, B ^a   Selam, J ^a   Vague, P ^a   Drouin, P ^a   Halimi, S ^a   Greszczak, W ^a   Czekalski, S ^a   Sieradzki, J ^a   Fovenyi, J ^a   Kerenyi, Z ^a   Kammerer, L ^a   Saudek, F ^a   Vondra, K ^a   Andel, M ^a   Drorakova, L ^a   Hepp, K D ^a   Koschinsky, T ^a   Lehnert, H ^a   Standl, E ^a   Marshall, S ^a   Boulton, A ^a   MacCuish, A ^a   Hyer, S ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE;

DRUG COST; DRUG INDUSTRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MICROALBUMINURIA; PRIORITY JOURNAL;

EID: 0030825298     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26029-0     Document Type: Letter

References (0)